Oral chemotherapy drugs are so expensive that they will be out of the financial reach of most Medicare patients even when the Part D doughnut hole closes in 2020, according to new research.
Oral chemotherapy drugs are so expensive that they will be out of the financial reach of most Medicare patients even when the Part D doughnut hole closes in 2020, according to new research.